Newborn Screening Market Size, Share, Forecast Report 2032
Newborn Screening Market By Product (Instruments and Assay Kits and Reagents), By Screening Test (Dry Blood Spot Test, Critical Congenital Heart Disease, Hearing Screen, Urine Test, and Other Tests), By End-User (Hospitals, Clinics, and Diagnostic Centers), And By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 845.31 Million | USD 1634.27 Million | 7.6% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global newborn screening market, 2024-2032 (USD Million)
- 2.2. Global newborn screening market: Snapshot
- Chapter 3. New Born Screening Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Global newborn screening market drivers: impact analysis
- 3.2.2. Growing newborn screening programs
- 3.2.3. Rising congenital diseases incidences
- 3.2.4. Rising government funding for newborn screening
- 3.2.5. Advancements in technologies used in newborn screening
- 3.3. Market Restraints
- 3.3.1. Global newborn screening market restraints: impact analysis
- 3.3.2. Lack of uniformity of newborn screening policies and procedures globally
- 3.3.3. False positive and false negative results
- 3.4. Opportunities
- 3.4.1. Partnerships of private investors with hospitals and diagnostic centers
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis, by product
- 3.6.2. Market attractiveness analysis, by screening test
- 3.6.3. Market attractiveness analysis, by end-user
- 3.6.4. Market attractiveness analysis, by region
- Chapter 4. Global Newborn Screening Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global newborn screening market: company market share, 2024
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New therapy launch
- 4.2.3. Agreements, partnerships, collaborations, and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Newborn Screening Market - Product Analysis
- 5.1. Global newborn screening market: product overview
- 5.1.1. Global newborn screening market revenue share, by product, 2024 and 2032
- 5.2. Instruments
- 5.2.1. Global newborn screening market by instruments, 2024-2032 (USD Million)
- 5.3. Assay Kits and Reagents
- 5.3.1. Global newborn screening market by assay kits and reagents, 2024-2032 (USD Million)
- 5.1. Global newborn screening market: product overview
- Chapter 6. Global Newborn Screening Market - Screening Test Analysis
- 6.1. Global newborn screening market: screening test overview
- 6.1.1. Global newborn screening market revenue share, by screening test, 2024 and 2032
- 6.2. Dry Blood Spot Tests
- 6.2.1. Global newborn screening market for dry blood spot tests, 2024-2032 (USD Million)
- 6.3. Critical Congenital Heart Disease (CCHD)
- 6.3.1. Global newborn screening market for critical congenital heart disease (CCHD), 2024-2032 (USD Million)
- 6.4. Hearing Screen
- 6.4.1. Global newborn screening market for hearing screen, 2024-2032 (USD Million)
- 6.5. Urine Test
- 6.5.1. Global newborn screening market for urine test, 2024-2032 (USD Million)
- 6.6. Other Tests
- 6.6.1. Global newborn screening market for other tests, 2024-2032 (USD Million)
- 6.1. Global newborn screening market: screening test overview
- Chapter 7. Global Newborn Screening Market - End-User Analysis
- 7.1. Global newborn screening market: end-user overview
- 7.1.1. Global newborn screening market revenue share, by end-user, 2024 and 2032
- 7.2. Hospitals
- 7.2.1. Global newborn screening market for hospitals, 2024-2032 (USD Million)
- 7.3. Clinics
- 7.3.1. Global newborn screening market for ambulatory surgical centers, 2024-2032 (USD Million)
- 7.4. Diagnostic Centers
- 7.4.1. Global newborn screening market for diagnostic centers, 2024-2032 (USD Million)
- 7.1. Global newborn screening market: end-user overview
- Chapter 8. Global Newborn Screening Market - Regional Analysis
- 8.1. Global newborn screening market: regional overview
- 8.1.1. Global newborn screening market revenue share, by region, 2024 and 2032
- 8.2. North America
- 8.2.1. North America newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.2.2. North America newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.2.3. North America newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.2.4.2. The U.S. newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.2.4.3. The U.S. newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.2.5. Canada
- 8.2.5.1. Canada newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.2.5.2. Canada newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.2.5.3. Canada newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.3. Europe
- 8.3.1. Europe newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.3.2. Europe newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.3.3. Europe newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.3.4. UK
- 8.3.4.1. UK newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.3.4.2. UK newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.3.4.3. UK newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.3.5. Germany
- 8.3.5.1. Germany newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.3.5.2. Germany newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.3.5.3. Germany newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.3.6. France
- 8.3.6.1. France newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.3.6.2. France newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.3.6.3. France newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.3.7.2. Rest of Europe newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.3.7.3. Rest of Europe newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.4.2. Asia Pacific newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.4.3. Asia Pacific newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.4.4. China
- 8.4.4.1. China newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.4.4.2. China newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.4.4.3. China newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.4.5.2. Japan newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.4.5.3. Japan newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.4.6. India
- 8.4.6.1. India newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.4.6.2. India newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.4.6.3. India newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.4.7.2. Rest of Asia Pacific newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.4.7.3. Rest of Asia Pacific newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.5.2. Latin America newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.5.3. Latin America newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.5.4.2. Brazil newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.5.4.3. Brazil newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.5.5.2. Rest of Latin America newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.5.5.3. Rest of Latin America newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa newborn screening market revenue, by product, 2024-2032 (USD Million)
- 8.6.2. The Middle East and Africa newborn screening market revenue, by screening test, 2024-2032 (USD Million)
- 8.6.3. The Middle East and Africa newborn screening market revenue, by end-user, 2024-2032 (USD Million)
- 8.1. Global newborn screening market: regional overview
- Chapter 9. Company Profile
- 9.1. Bio-Rad Laboratories
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. GE Healthcare
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Thermo Fisher Scientific
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Agilent Technologies
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. ZenTech
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Trivitron Healthcare
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. PerkinElmer
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Natus Medical Incorporated
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.9. MP Biomedicals
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product portfolio
- 9.9.4. Business strategy
- 9.9.5. Recent developments
- 9.10. Medtronic
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product portfolio
- 9.10.4. Business strategy
- 9.10.5. Recent developments
- 9.1. Bio-Rad Laboratories
Table Of Figures
List of Figures
1. Market research process
2. Market methodology
3. Global newborn screening market revenue, 2024–2032 (USD Million)
4. Porter’s Five Forces Analysis
5. Newborn screening market attractiveness analysis, by product
6. Newborn screening market attractiveness analysis, by screening test
7. Newborn screening market attractiveness analysis, by end-user
8. Newborn screening market attractiveness analysis, by region
9. Company market share analysis, 2024
10. Global newborn screening market revenue share by product, 2024 and 2032
11. Global newborn screening market for instruments,2024–2032 (USD Million)
12. Global newborn screening market for assay kits and reagents, 2024–2032 (USD Million)
13. Global newborn screening market revenue share by screening test, 2024 and 2032
14. Global newborn screening market for dry blood spot tests, 2024–2032 (USD Million)
15. Global newborn screening market for critical congenital heart disease (CCHD),2024–2032 (USD Million)
16. Global newborn screening market for hearing screen, 2024–2032 (USD Million)
17. Global newborn screening market for urine screen, 2024–2032 (USD Million)
18. Global newborn screening market for other tests, 2024–2032 (USD Million)
19. Global newborn screening market revenue share by end-user, 2024 and 2032
20. Global newborn screening market for hospitals, 2024–2032 (USD Million)
21. Global newborn screening market for clinics, 2024–2032 (USD Million)
22. Global newborn screening market for diagnostic centers, 2024–2032 (USD Million)
23. Global newborn screening market revenue share by region, 2024 and 2032
24. North America newborn screening market, 2024–2032 (USD Million)
25. Europe newborn screening market, 2024–2032 (USD Million)
26. Asia Pacific newborn screening market, 2024–2032 (USD Million)
27. Latin America newborn screening market, 2024–2032 (USD Million)
28. The Middle East and Africa newborn screening market, 2024–2032 (USD Million)
Table Of Tables
List of Tables
1. Newborn screening market: Market Snapshot
2. Drivers of the global newborn screening market: impact analysis
3. Restraints of the global newborn screening market: impact analysis
4. North America newborn screening market revenue, by product, 2024–2032 (USD Million)
5. North America newborn screening market revenue, by screening test, 2024–2032 (USD Million)
6. North America newborn screening market revenue, by end-user, 2024–2032 (USD Million)
7. The U.S. newborn screening market revenue, by product, 2024–2032 (USD Million)
8. The U.S. newborn screening market revenue, by screening test, 2024–2032 (USD Million)
9. The U.S. newborn screening market revenue, by end-user, 2024–2032 (USD Million)
10. Canada newborn screening market revenue, by product, 2024–2032 (USD Million)
11. Canada newborn screening market revenue, by screening test, 2024–2032 (USD Million)
12. Canada newborn screening market revenue, by end-user, 2024–2032 (USD Million)
13. Europe newborn screening market revenue, by product, 2024–2032 (USD Million)
14. Europe newborn screening market revenue, by screening test, 2024–2032 (USD Million)
15. Europe newborn screening market revenue, by end-user, 2024–2032 (USD Million)
16. U.K. newborn screening market revenue, by product, 2024–2032 (USD Million)
17. U.K. newborn screening market revenue, by screening test, 2024–2032 (USD Million)
18. U.K. newborn screening market revenue, by end-user, 2024–2032 (USD Million)
19. Germany newborn screening market revenue, by product, 2024–2032 (USD Million)
20. Germany newborn screening market revenue, by screening test, 2024–2032 (USD Million)
21. Germany newborn screening market revenue, by end-user, 2024–2032 (USD Million)
22. France newborn screening market revenue, by product, 2024–2032 (USD Million)
23. France newborn screening market revenue, by screening test, 2024–2032 (USD Million)
24. France newborn screening market revenue, by end-user, 2024–2032 (USD Million)
25. Rest of Europe newborn screening market revenue, by product, 2024–2032 (USD Million)
26. Rest of Europe newborn screening market revenue, by screening test, 2024–2032 (USD Million)
27. Rest of Europe newborn screening market revenue, by end-user, 2024–2032 (USD Million)
28. Asia Pacific newborn screening market revenue, by product, 2024–2032 (USD Million)
29. Asia Pacific newborn screening market revenue, by screening test, 2024–2032 (USD Million)
30. Asia Pacific newborn screening market revenue, by end-user, 2024–2032 (USD Million)
31. China newborn screening market revenue, by product, 2024–2032 (USD Million)
32. China newborn screening market revenue, by screening test, 2024–2032 (USD Million)
33. China newborn screening market revenue, by end-user, 2024–2032 (USD Million)
34. Japan newborn screening market revenue, by product, 2024–2032 (USD Million)
35. Japan newborn screening market revenue, by screening test, 2024–2032 (USD Million)
36. Japan newborn screening market revenue, by end-user, 2024–2032 (USD Million)
37. India newborn screening market revenue, by product, 2024–2032 (USD Million)
38. India newborn screening market revenue, by screening test, 2024–2032 (USD Million)
39. India newborn screening market revenue, by end-user, 2024–2032 (USD Million)
40. Rest of Asia Pacific newborn screening market revenue, by product, 2024–2032 (USD Million)
41. Rest of Asia Pacific newborn screening market revenue, by screening test, 2024–2032 (USD Million)
42. Rest of Asia Pacific newborn screening market revenue, by end-user, 2024–2032 (USD Million)
43. Latin America newborn screening market revenue, by product, 2024–2032 (USD Million)
44. Latin America newborn screening market revenue, by screening test, 2024–2032 (USD Million)
45. Latin America newborn screening market revenue, by end-user, 2024–2032 (USD Million)
46. Brazil newborn screening market revenue, by product, 2024–2032 (USD Million)
47. Brazil newborn screening market revenue, by screening test, 2024–2032 (USD Million)
48. Brazil newborn screening market revenue, by end-user, 2024–2032 (USD Million)
49. Rest of Latin America newborn screening market revenue, by product, 2024–2032 (USD Million)
50. Rest of Latin America newborn screening market revenue, by screening test, 2024–2032 (USD Million)
51. Rest of Latin America newborn screening market revenue, by end-user, 2024–2032 (USD Million)
52. The Middle East and Africa newborn screening market revenue, by product, 2024–2032 (USD Million)
53. The Middle East and Africa newborn screening market revenue, by screening test, 2024–2032 (USD Million)
54. The Middle East and Africa newborn screening market revenue, by end-user, 2024–2032 (USD Million)
Methodology
FrequentlyAsked Questions
Newborn screening is a public health program that tests infants shortly after birth for a range of treatable but often undetected conditions. By identifying these conditions early, healthcare providers can initiate timely interventions, preventing serious health complications.
According to a study, the global newborn screening market size was worth around USD 845.31 million in 2023 and is expected to reach USD 1634.27 million by 2032.
The global newborn screening market is expected to grow at a CAGR of 7.6% during the forecast period.
North America is expected to dominate the newborn screening market over the forecast period.
Leading players in the global newborn screening market include Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific, Agilent Technologies, ZenTech, Trivitron Healthcare, PerkinElmer, Natus Medical, MP Biomedicals, and Medtronic, among others.
HappyClients
